Profile data is unavailable for this security.
About the company
Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company operates in two segments specialty pharma and lifestyle and aesthetics. Specialty pharma segment includes the trade and production of drugs and preparations in the field of human immunodeficiency virus (HIV), oncology, rheumatology, neurology as well as cardiovascular diseases and other chronic diseases. Its lifestyle and aesthetics segment is an outcome of new subsidiary M1 Aesthetics GmbH which is into marketing of pharmaceutical, medical and med tech products for aesthetic surgery and cosmetic dermatology. The Company acts as a wholesaler and parallel importer. Its business is carried out by there companies Haemato pharma AG, Haemato Med GmbH, M1 Aesthetics GmbH. It offers related support services.
- Revenue in EUR (TTM)260.81m
- Net income in EUR9.61m
- Incorporated2003
- Employees78.00
- LocationHaemato AGLilienthalstrasse 3aSCHOENEFELD 12529GermanyDEU
- Phone+49 30 897308670
- Fax+49 30 897308679
- Websitehttps://haemato.de/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haemato AG | 260.81m | 9.61m | 51.85m | 78.00 | 5.37 | 0.3453 | 4.82 | 0.1988 | 1.84 | 1.84 | 50.10 | 28.67 | 1.47 | 9.80 | 12.48 | 3,343,690.00 | 5.41 | 2.01 | 6.45 | 2.70 | 7.56 | 8.42 | 3.68 | 1.21 | 1.66 | -- | 0.0203 | 157.20 | -12.95 | -3.03 | 25.39 | 3.32 | -5.75 | -16.74 |
| Rafael Holdings Inc | 865.07k | -26.34m | 52.22m | 21.00 | -- | 0.738 | -- | 60.36 | -0.8471 | -0.8471 | 0.0284 | 1.63 | 0.0107 | -- | 3.35 | 49,000.00 | -32.33 | -45.03 | -37.62 | -51.75 | 89.70 | -- | -3,034.89 | -8,772.74 | 3.98 | -- | 0.0074 | -- | 43.96 | -28.51 | 11.30 | -- | -47.65 | -- |
| Chunghwa Chemical Synthsis&Biotech CoLtd | 26.09m | -2.75m | 52.84m | 243.00 | -- | 0.6163 | 22.61 | 2.03 | -1.86 | -1.86 | 17.54 | 41.78 | 0.2102 | 0.9037 | 5.40 | -- | -2.21 | 8.04 | -2.45 | 9.34 | 15.54 | 41.53 | -10.53 | 19.02 | 1.10 | -- | 0.2005 | 23.00 | -35.42 | 3.10 | -79.98 | -14.64 | -1.83 | -24.86 |
| Janel Corp | 174.40m | 4.23m | 52.86m | 353.00 | 12.69 | 2.44 | 7.31 | 0.3031 | 4.18 | 4.18 | 172.09 | 21.75 | 1.47 | 32.80 | 4.14 | 587,657.30 | 4.02 | 1.76 | 13.35 | 5.33 | 31.33 | 26.69 | 2.73 | 0.9608 | 0.7013 | 3.10 | 0.3913 | 0.00 | 13.24 | 20.27 | 2,155.61 | -- | -14.58 | -- |
| LifeVantage Corp | 176.58m | 6.61m | 53.02m | 232.00 | 8.22 | 1.91 | 5.85 | 0.3003 | 0.5998 | 0.5998 | 16.16 | 2.58 | 3.24 | 2.45 | 96.73 | 905,370.70 | 12.12 | 9.17 | 18.91 | 14.08 | 78.75 | 80.73 | 3.74 | 2.93 | 1.03 | -- | 0.00 | 35.06 | 14.17 | -0.3794 | 233.84 | -3.22 | -12.55 | -- |
